The global ELISpot and FluoroSpot Assays Market boasts a total value of $274 million in 2022 and is projected to register a growth rate of 7.3% to reach a value of $390 million by 2027. The expansion of this market is majorly due to upsurging cases of chronic diseases such as cancer as well as growing Growth in biotechnology and biopharmaceutical industries. However, availability of other detection technologies is one of the challenge for which may inhibit the growth of this market. 

Globally, the number of diabetics is expected to grow from 643 million in 2030 to 783 million by 2045. Diabetes resulted in 6.7 million deaths worldwide in 2021, while 541 million people are estimated to be at risk of developing diabetes (Source: International Diabetes Federation). 

Browse 134 market data Tables and 47 Figures spread through 192 Pages and in-depth TOC on "ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplants, Vaccine Development), End User (Hospitals & Clinical Labs, Research Institutes) - Global Forecast to 2027"

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124350584 

The WHO estimated CVD to be the leading cause of death worldwide; it claimed over 17.9 million lives in 2008. The disease is predicted to claim 23.6 million lives by 2030, mainly due to strokes and heart attacks. 

EliSpot Assay kits in the kits product segment to witness the highest shares during the forecast period.”

Based on the product, Based on the product, the ELISpot and FluoroSpot Assays Market is classified into Assay Kits (By Technique - ELISpot Assay Kits, FluoroSpot Assay Kits., By Utility - Research Kits, Diagnostic Kits., By Analyte - T-cell-based Kits, B-cell-based Kits, Other Analyte Kits), Analyzers, Ancillary Products. The EliSpot Assay kits,segment is expected to dominate because of its wider application as these are widely used for research as well as diagnostic applications and the advantages in terms of high specificity and sensitivity and better detection limits as compared to other assays such as ELISA. likewise, several players are focusing on introducing new products in the market to strengthen their product offerings. These are the key factors driving the growth of the EliSpot kits in the market.

US dominates the North American ELISpot and FluoroSpot Assays Market

Based on the North America region, the ELISpot and FluoroSpot Assays Market is divided into US and Canada. US is expected to dominate the ELISpot and FluoroSpot Assays Market. rising prevalence of chronic diseases, increasing focus on vaccine development, rapidly increasing geriatric population, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers., are the key factor driving market growth in the US.

The major players in the ELISpot and FluoroSpot Assays Market are Oxford Immunotec (UK), Cellular Technology Limited (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam plc. (UK), Bio-Techne.(US), Mikrogen Diagnostik (Germany), Autoimmun Diagnostika GmbH (Germany), U-CyTech (Netherland), and Medix Biochemica (Finland)